Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
종목 코드 ADVB
회사 이름Advanced Biomed Inc
상장일Mar 06, 2025
CEO- -
직원 수31
유형Ordinary Share
회계 연도 종료Mar 06
주소401 Ryland St
도시RENO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호89502
전화1862120510823
웹사이트http://www.advanbiomed.com/
종목 코드 ADVB
상장일Mar 06, 2025
CEO- -
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음